LEADER 02436oam  22007091  450 
001 9910821988703321
005 20240131145348.0
010   $a0-429-91257-9
010   $a0-429-89834-7
010   $a0-429-47357-5
010   $a1-283-12520-X
010   $a9786613125200
010   $a1-84940-228-0
024 8 $a10.4324/9780429473579
035   $a(CKB)2670000000093863
035   $a(EBL)712333
035   $a(OCoLC)729167085
035   $a(SSID)ssj0000521900
035   $a(PQKBManifestationID)12199664
035   $a(PQKBTitleCode)TC0000521900
035   $a(PQKBWorkID)10527385
035   $a(PQKB)10390333
035   $a(MiAaPQ)EBC712333
035   $a(Au-PeEL)EBL712333
035   $a(CaPaEBR)ebr10477644
035   $a(CaONFJC)MIL312520
035   $a(OCoLC)1063632675
035   $a(OCoLC-P)1063632675
035   $a(FlBoTFG)9780429473579
035   $a(OCoLC)37208335
035   $a(FINmELB)ELB140149
035   $a(EXLCZ)992670000000093863
100   $a20180517d2018      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aDeath anxiety and clinical practice /$fRobert Langs
205   $a1st
210  1$aLondon :$cRoutledge,$d2018.
215   $a1 online resource (271 p.)
300   $aDescription based upon print version of record.
311   $a0-367-10488-1 
311   $a1-85575-141-0 
320   $aIncludes bibliographical references (p. 243-244) and index.
327   $apt. 1. Death issues : basic perspectives -- pt. 2. Death issues and the patient -- pt. 3. Death issues and the therapist.
330   $aRobert Langs argues that death anxiety is neglected - in part, because of treatment failures due to countertransference interferences during treatment. He then discusses the technical issues connected with this, whilst introducing the controversial concept that mental activities are derived from immune system activities.
606   $aFear of death
606   $aPsychotherapy
606   $aDeath$xPsychological aspects
615  0$aFear of death.
615  0$aPsychotherapy.
615  0$aDeath$xPsychological aspects.
676   $a155.9/37
700   $aLangs$b Robert$f1928-$0181441
801  0$bOCoLC-P
801  1$bOCoLC-P
906   $aBOOK
912   $a9910821988703321
996   $aDeath anxiety and clinical practice$94005833
997   $aUNINA